Compositions and uses in the activation of thermogenesis (Machine-translation by Google Translate, not legally binding)
Compositions and uses in the activation of thermogenesis. The present invention relates to the combined use of stilbenoid selected from resveratrol, pterostilbene and piceatannol and at least one flavonol selected from quercetin, quercetin 4'-o-glucoside, quercetin 3,4 'diglucoside, kaempf...
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | English Spanish |
Published |
12.03.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Compositions and uses in the activation of thermogenesis. The present invention relates to the combined use of stilbenoid selected from resveratrol, pterostilbene and piceatannol and at least one flavonol selected from quercetin, quercetin 4'-o-glucoside, quercetin 3,4 'diglucoside, kaempferol, myricetin and isorhamnetin for the manufacture of a composition for the treatment and/or prevention of overweight/obesity, disorders of body temperature and/or pathologies associated to both conditions in mammals. Furthermore, the present invention relates to pharmaceutical compositions, food supplements and cosmetic compositions comprising said composition. (Machine-translation by Google Translate, not legally binding)
Composiciones y usos en la activación de la termogénesis. La presente invención se refiere al uso combinado de estilbenoide seleccionado de resveratrol, pterostilbeno y piceatannol y al menos un flavonol seleccionado de quercetina, quercetina 4'-O-glucósido, quercetina 3,4' diglucósido, kaempferol, miricetina e isorhamnetina para la fabricación de una composición para el tratamiento y/o la prevención de sobrepeso/obesidad, desórdenes de temperatura corporal y/o patologías asociadas a ambas condiciones en mamíferos. Además la presente invención se refiere a composiciones farmacéuticas, complementos alimenticios y composiciones cosméticas que comprenden dicha composición. |
---|---|
Bibliography: | Application Number: ES20130031329 |